chr11-2160994-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001042376.3(INS-IGF2):​c.-17-6T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.71 in 1,609,954 control chromosomes in the GnomAD database, including 415,985 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 32035 hom., cov: 35)
Exomes 𝑓: 0.72 ( 383950 hom. )

Consequence

INS-IGF2
NM_001042376.3 splice_region, intron

Scores

2
Splicing: ADA: 0.1228
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0740

Publications

236 publications found
Variant links:
Genes affected
INS (HGNC:6081): (insulin) This gene encodes insulin, a peptide hormone that plays a vital role in the regulation of carbohydrate and lipid metabolism. After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified, including insulin-dependent diabetes mellitus, permanent neonatal diabetes diabetes mellitus, maturity-onset diabetes of the young type 10 and hyperproinsulinemia. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. [provided by RefSeq, May 2020]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-2160994-A-T is Benign according to our data. Variant chr11-2160994-A-T is described in ClinVar as Benign. ClinVar VariationId is 304059.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.926 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042376.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INS
NM_000207.3
MANE Select
c.-17-6T>A
splice_region intron
N/ANP_000198.1
INS
NM_001185098.2
c.-23T>A
5_prime_UTR
Exon 1 of 2NP_001172027.1
INS-IGF2
NM_001042376.3
c.-17-6T>A
splice_region intron
N/ANP_001035835.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INS
ENST00000397262.5
TSL:1
c.-23T>A
5_prime_UTR
Exon 1 of 2ENSP00000380432.1
INS
ENST00000381330.5
TSL:1 MANE Select
c.-17-6T>A
splice_region intron
N/AENSP00000370731.5
INS-IGF2
ENST00000397270.1
TSL:1
c.-17-6T>A
splice_region intron
N/AENSP00000380440.1

Frequencies

GnomAD3 genomes
AF:
0.611
AC:
92830
AN:
152032
Hom.:
32028
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.263
Gnomad AMI
AF:
0.666
Gnomad AMR
AF:
0.725
Gnomad ASJ
AF:
0.709
Gnomad EAS
AF:
0.947
Gnomad SAS
AF:
0.831
Gnomad FIN
AF:
0.792
Gnomad MID
AF:
0.788
Gnomad NFE
AF:
0.719
Gnomad OTH
AF:
0.669
GnomAD2 exomes
AF:
0.734
AC:
178240
AN:
242726
AF XY:
0.745
show subpopulations
Gnomad AFR exome
AF:
0.247
Gnomad AMR exome
AF:
0.769
Gnomad ASJ exome
AF:
0.703
Gnomad EAS exome
AF:
0.953
Gnomad FIN exome
AF:
0.797
Gnomad NFE exome
AF:
0.720
Gnomad OTH exome
AF:
0.737
GnomAD4 exome
AF:
0.720
AC:
1049977
AN:
1457804
Hom.:
383950
Cov.:
61
AF XY:
0.725
AC XY:
525501
AN XY:
725156
show subpopulations
African (AFR)
AF:
0.245
AC:
8177
AN:
33438
American (AMR)
AF:
0.762
AC:
33884
AN:
44470
Ashkenazi Jewish (ASJ)
AF:
0.705
AC:
18395
AN:
26076
East Asian (EAS)
AF:
0.959
AC:
38023
AN:
39664
South Asian (SAS)
AF:
0.827
AC:
71293
AN:
86168
European-Finnish (FIN)
AF:
0.792
AC:
40663
AN:
51324
Middle Eastern (MID)
AF:
0.789
AC:
4293
AN:
5442
European-Non Finnish (NFE)
AF:
0.713
AC:
792116
AN:
1110992
Other (OTH)
AF:
0.716
AC:
43133
AN:
60230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
17870
35741
53611
71482
89352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19814
39628
59442
79256
99070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.610
AC:
92854
AN:
152150
Hom.:
32035
Cov.:
35
AF XY:
0.624
AC XY:
46388
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.263
AC:
10901
AN:
41518
American (AMR)
AF:
0.725
AC:
11094
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.709
AC:
2461
AN:
3470
East Asian (EAS)
AF:
0.948
AC:
4894
AN:
5164
South Asian (SAS)
AF:
0.831
AC:
4010
AN:
4824
European-Finnish (FIN)
AF:
0.792
AC:
8397
AN:
10602
Middle Eastern (MID)
AF:
0.793
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
0.719
AC:
48839
AN:
67968
Other (OTH)
AF:
0.673
AC:
1422
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1574
3149
4723
6298
7872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.676
Hom.:
6698
Bravo
AF:
0.588
Asia WGS
AF:
0.841
AC:
2925
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Autosomal recessive DOPA responsive dystonia (1)
-
-
1
Maturity onset diabetes mellitus in young (1)
-
-
1
Maturity-onset diabetes of the young type 10 (1)
-
-
1
Transient Neonatal Diabetes, Dominant/Recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.2
DANN
Benign
0.75
PhyloP100
-0.074
PromoterAI
0.018
Neutral
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.12
dbscSNV1_RF
Benign
0.39
SpliceAI score (max)
0.38
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.38
Position offset: -6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs689; hg19: chr11-2182224; API